Using sequence-specific siRNAs (Figure 3) or the quinolinyl thiazolinone derivative, RO-3306 ([14], Figure 4), to inhibit CCNB1/cdk1, we observed decreased cell viability and an increased number of apoptotic cells in all NB cell lines investigated. The gene discussed is CDK1; the disease is neuroblastoma.